-
1
-
2
-
3
-
4
-
5
-
6
-
7
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20